PPR-161 - Pharmacist-assessed adherence and quality of life in patients with epilepsy

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-161
• By: PETRIDES, Michael (Pharmacy Programme, Department of Health Sciences, University of NIcosia, Cyprus)
• Co-author(s): Mr Michael Petrides (Pharmacy Programme, Department of Health Sciences, University of NIcosia, Nicosia, Cyprus / Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Campus (Dragana) Building 5, 68100 Alexandroupolis, Greece. , Greece / Bioactive Molecules Research Center (BioMoReC), University of Nicosia, Nicosia, Cyprus)
  Aliki Peletidi (Pharmacy Programme, Department of Health Sciences, University of NIcosia, Nicosia, Cyprus / Bioactive Molecules Research Center (BioMoReC), University of Nicosia, Nicosia, Cyprus)
  Dr Evangelia Nena (Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Campus (Dragana) Building 5, 68100 Alexandroupolis, Greece. , Greece)
  Professor Theodoros Konstantinidis (Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Campus (Dragana) Building 5, 68100 Alexandroupolis, Greece. , Greece)
  Dr Christos Kontogiorgis (Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Campus (Dragana) Building 5, 68100 Alexandroupolis, Greece. , Greece)
  
• Abstract:

  Introduction
  Epilepsy is recognised as a prevalent chronic noncommunicable neurological disorder, affecting approximately 50 million individuals worldwide, across all age groups. Community pharmacists are uniquely positioned to improve medication adherence, a critical factor in preventing breakthrough seizures that can drastically affect patients' ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login